REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 220 filers reported holding REVANCE THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.25 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,269,443 | -56.6% | 110,675 | +21.7% | 0.00% | 0.0% |
| Q2 2023 | $2,928,340 | 0.0% | 90,914 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $2,928,340 | +100.8% | 90,914 | +15.1% | 0.00% | 0.0% |
| Q4 2022 | $1,458,082 | -99.9% | 78,986 | +13.1% | 0.00% | 0.0% |
| Q3 2022 | $1,885,005,000 | +98.2% | 69,815 | +1.4% | 0.00% | – |
| Q2 2022 | $951,258,000 | -25.9% | 68,832 | +4.6% | 0.00% | -100.0% |
| Q1 2022 | $1,283,705,000 | +19.5% | 65,831 | 0.0% | 0.00% | – |
| Q4 2021 | $1,074,362,000 | -89.4% | 65,831 | -81.8% | 0.00% | -100.0% |
| Q3 2021 | $10,100,587,000 | -8.0% | 362,548 | -2.1% | 0.00% | -20.0% |
| Q2 2021 | $10,975,514,000 | +2.2% | 370,294 | -3.6% | 0.01% | 0.0% |
| Q1 2021 | $10,737,159,000 | +1.1% | 384,156 | +2.5% | 0.01% | 0.0% |
| Q4 2020 | $10,618,318,000 | +900.3% | 374,676 | +787.4% | 0.01% | +400.0% |
| Q3 2020 | $1,061,486,000 | +6.2% | 42,223 | +3.1% | 0.00% | 0.0% |
| Q2 2020 | $999,633,000 | +92.6% | 40,935 | +16.7% | 0.00% | – |
| Q1 2020 | $518,947,000 | +6.0% | 35,064 | +16.2% | 0.00% | – |
| Q4 2019 | $489,579,000 | +167.3% | 30,165 | +114.1% | 0.00% | – |
| Q3 2019 | $183,131,000 | +8.3% | 14,087 | +8.1% | 0.00% | – |
| Q2 2019 | $169,025,000 | -17.7% | 13,032 | 0.0% | 0.00% | – |
| Q1 2019 | $205,385,000 | +64486.5% | 13,032 | +40.1% | 0.00% | – |
| Q4 2015 | $318,000 | +22.8% | 9,300 | +6.9% | 0.00% | – |
| Q3 2015 | $259,000 | -6.8% | 8,700 | 0.0% | 0.00% | – |
| Q2 2015 | $278,000 | -74.8% | 8,700 | -86.7% | 0.00% | -100.0% |
| Q4 2014 | $1,104,000 | -12.4% | 65,200 | 0.0% | 0.00% | 0.0% |
| Q3 2014 | $1,260,000 | -43.2% | 65,200 | 0.0% | 0.00% | -50.0% |
| Q2 2014 | $2,217,000 | +45.8% | 65,200 | +35.0% | 0.00% | 0.0% |
| Q1 2014 | $1,521,000 | – | 48,300 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 4,405,039 | $118,936,000 | 9.40% |
| Essex Woodlands Management, Inc. | 457,085 | $12,341,000 | 5.10% |
| Evolutionary Tree Capital Management, LLC | 191,868 | $5,180,000 | 4.98% |
| Ghost Tree Capital, LLC | 390,000 | $10,530,000 | 2.96% |
| Antara Capital LP | 4,069,400 | $109,874,000 | 2.90% |
| RICE HALL JAMES & ASSOCIATES, LLC | 896,754 | $24,212,000 | 1.40% |
| Jericho Capital Asset Management L.P. | 714,000 | $19,278,000 | 1.22% |
| Antara Capital LP | 1,600,000 | $43,200,000 | 1.14% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 120,000 | $3,240,000 | 1.04% |
| TANG CAPITAL MANAGEMENT LLC | 287,500 | $7,763,000 | 0.95% |